NNN — Nanosynth Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Nanosynth, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
R2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.503 | 0.109 | 0.075 | 3.74 | 3.76 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.334 | 0.255 | 0.066 | 1.93 | 0.079 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.837 | 0.382 | 0.316 | 5.73 | 3.86 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.088 | 0.504 | 0.011 | 0.026 | 0.042 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Total Assets | 1.6 | 1.71 | 0.705 | 7.52 | 5.67 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.828 | 0.807 | 0.667 | 0.605 | 0.707 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.964 | 1.04 | 0.676 | 0.545 | 0.707 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.636 | 0.668 | 0.029 | 6.98 | 4.96 |
| Total Liabilities & Shareholders' Equity | 1.6 | 1.71 | 0.705 | 7.52 | 5.67 |
| Total Common Shares Outstanding |